Single-arm study | Blinatumomab added to chemotherapy in infant lymphoblastic leukemia

Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia – New England Journal of Medicinev (link to abstract – $ for full-text)

News Release: Immunotherapy strongly improves prognosis of babies with leukemia – Princess Máxima Center

Commentary on Twitter

In this study, the addition of blinatumomab to standard chemotherapy improved disease-free and overall survival among infants with KMT2A-rearranged ALL, with minimal additional toxic effects. https://t.co/fNKOaQQfdN

— NEJM (@NEJM) April 26, 2023